Irving London
Irving M. London (July 24, 1918 – May 23, 2018) was a hematologist and geneticist. He was an associate professor of medicine at Columbia University College of Physicians and Surgeons when he was selected to be the founding chair of the department of medicine at the Albert Einstein College of Medicine in 1955.[1] He was recruited to become the founding director of the Harvard-MIT Program in Health Sciences and Technology in 1970.[2][3]
Irving M. London | |
|---|---|
| Born | 24 July 1918 Malden, Massachusetts, U.S. |
| Died | 7 May 2018 (aged 99) |
| Alma mater | Harvard University Hebrew College Harvard Medical School |
| Known for | Molecular regulation of hemoglobin synthesis |
| Awards | Theobald Smith Award in Medical Sciences of the American Association for the Advancement of Science (1953) |
| Scientific career | |
| Fields | Health Sciences and Technology |
| Institutions | Harvard University Massachusetts Institute of Technology |
London graduated from Harvard College and Harvard Medical School.[4] London died on May 23, 2018, two months before his 100th birthday.[5]
References
- "Einstein Medical Heads – Three Department Chairmen Named, Filling Senior Faculty". New York Times. March 21, 1955. p. 26. Retrieved 17 January 2016.
- "Web Pages of the Harvard-MIT HST Program". Retrieved 2015-12-25.
- "Web pages of the Albert Einstein College of Medicine". Retrieved 2015-12-25.
- https://meded.hms.harvard.edu/irving-m-london
- "Irving London, founding director of Harvard-MIT Program in Health Sciences and Technology, dies at 99". MIT News. 25 May 2018.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.